A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription

Journal of Experimental Medicine

Volumn 190, Issue 12, 1999, Pages 1793-1799

  Van Den Eynde, Benoît J ^a,b   Gaugler, Béatrice ^a,b,e   Probst Kepper, Michael ^a,b   Michaux, Lucienne ^b   Devuyst, Olivier ^c   Lorge, Francis ^b   Weynants, Patrick ^a,b,d   Boon, Thierry ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^e INSTITUT PAOLI CALMETTES   (France)

Author keywords

Antisense; Cytolytic T lymphocytes; Peptides; Renal cell carcinoma

Indexed keywords

HLA B7 ANTIGEN; RNA;

ANTIGEN EXPRESSION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DNA LIBRARY; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; NUCLEOTIDE SEQUENCE; POLYADENYLATION; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BASE SEQUENCE; CARCINOMA, RENAL CELL; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033397770     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.12.1793     Document Type: Article

References (26)

1. Van den Eynde, B., and P. van der Bruggen. 1997. T cell-defined tumor antigens. Curr. Opin. Immunol. 9:684-693.
2. Gaugler, B., N. Brouwenstijn, V. Vantomme, J.-P. Szikora, C.W. Van der Spek, J.-J. Patard, T. Boon, P. Schrier, and B.J. Van den Eynde. 1996. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics. 44:323-330.
3. Brändle, D., F. Brasseur, P. Weynants, T. Boon, and B. Van den Eynde. 1996. A mutated HLA-A2 molecule recognized by autologons cytotoxic T lymphocytes on a human renal cell carcinoma. J. Exp. Med. 183:2501-2508.
4. Gaudin, C., F. Kremer, E. Angevin, V. Scott, and F. Triebel. 1999. A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma. J. Immunol. 162:1730-1738.
5. Bernhard, H., J. Karbach, T. Wölfel, P. Busch, S. Störkel, M. Stöckle, C. Wölfel, B. Seliger, C. Huber, K.-H. Meyer zum Büschenfelde, and A. Knuth. 1994. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones. Int. J. Cancer. 59:837-842.
6. Brouwenstijn, N., C. Hoogstraten, E.M.E. Verdegaal, C.W. Van der Spek, J.G. Deckers, A. Mulder, S. Osanto, and P.I. Schrier. 1998. Definition of unique and shared T-cell defined tumor antigens in human renal cell carcinoma. J. Immunother. 21:427-434.
7. Gazdar, A.F., and H.K. Oie. 1986. Re: Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 46:6011-6012.
8. Detrisac, C.J., M.A. Sens, J. Garvin, S.S. Spicer, and D.A. Sens. 1984. Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int. 25:383-390.
9. Deen, P.M.T., and C.H. van Os. 1998. Epithelial aquaporins. Curr. Opin. Cell Biol. 10:435-442.
10. Guéguen, M., J.-J. Patard, B. Gaugler, F. Brasseur, J.-C. Renauld, P.J. Van Cangh, T. Boon, and B. Van den Eynde. 1998. An antigen recognized by autologous CTL on a human bladder carcinoma. J. Immunol. 160:6188-6194.
11. De Plaen, E., C. Lurquin, V. Brichard, P. van der Bruggen, J.-C. Renauld, P. Coulie, J.-P. Szikora, T. Wölfel, A. Van Pel, and T. Boon. 1997. Cloning of genes coding for antigens recognized by cytolytic T lymphocytes. In The Immunology Methods Manual. I. Letkovits, editor. Academic Press Ltd., London. 692-718.
12. De Plaen, E., C. Lurquin, B. Lethé, P. van der Bruggen, V. Brichard, J.-C. Renauld, P. Coulie, A. Van Pel, and T. Boon. 1997. Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes. Methods. 12: 125-142.
13. Brouwenstijn, N., B. Gaugler, K.M. Krüse, C.W. Van der Spek, A. Mulder, S. Osanto, B.J. Van den Eynde, and P.I. Schrier. 1996. Renal cell carcinoma-specific lysis by cytotoxic T lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Int. J. Cancer. 68:177-182.
14. Rammensee, H.-G., J. Bachmann, and S. Stevanovic. 1997. MHC Ligands and Peptide Motifs. Molecular Biology Intelligence Unit. Springer-Verlag, Heidelberg, 462 pp.
15. Lethé, B., P. van der Bruggen, F. Brasseur, and T. Boon. 1997. MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific CTL. Melanoma Res. 7(Suppl. 2): S83-S88.
16. Simons, R.W., and N. Kleckner. 1988. Biological regulation by antisense RNA in prokaryotes. Annu. Rev. Genet. 22:567-600.
17. Vanhée-Brossollet, C., and C. Vaquero. 1998. Do natural anti-sense transcripts make sense in eukaryotes? Gene. 211:1-9.
18. Mayrand, S.-M., and W.R. Green. 1998. Non-traditionally derived CTL epitopes: exceptions that prove the rules? Immunol. Today. 19:551-556.
19. Guilloux, Y., S. Lucas, V.G. Brichard, A. Van Pel, C. Viret, E. De Plaen, F. Brasseur, B. Lethé, F. Jotereau, and T. Boon. 1996. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J. Exp. Med. 183:1173-1183.
20. Coulie, P.G., F. Lehmann, B. Lethé, J. Herman, C. Lurquin, M. Andrawiss, and T. Boon. 1995. A mutated intron sequence codes tor an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA. 92:7976-7980.
21. Lupetti, R., P. Pisarra, A. Verrecchia, C. Farina, G. Nicolini, A. Anichini, C. Bordignon, M. Sensi, G. Partniani, and C. Traversari. 1998. Translation of a retained intron in tyrosinase-related protein (TRP)-2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. J. Exp. Med. 188:1005-1016.
22. Robbins, P.F., M. El-Gamil, Y.F. Li, E.B. Fitzgerald, Y. Kawakami, and S.A. Rosenberg. 1997. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. J. Immunol. 159:303-308.
23. Wang, R.-F., S.L. Johnston, G. Zeng, S.L. Topalian, D.J. Schwartzentruber, and S.A. Rosenberg. 1998. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. J. Immunol. 161:3596-3606.
24. Wang, R.-F., M.R. Parkhurst, Y. Kawakami, P.F. Robbins, and S.A. Rosenberg. 1996. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J. Exp. Med. 183:1131-1140.
25. Aarnoudse, C.A., P.B. van den Doel, B. Heemskerk, and P.I. Schrier. 1999. Interleukin-2-induced, melanoma-specific T cells recognize camel, an unexpected translation product of LAGE-1. Int. J. Cancer. 82:442-448.
26. Skipper, J.C.A., R.C. Hendrickson, P.H. Gulden, V. Brichard, A. Van Pel, Y. CHen, J. Shabanowitz, T. Wölfel, C.L. Slingluff, Jr., T. Boon, et al. 1996. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 183:527-534.